Abstract
Controlling elevated tissue-specific levels of cortisol may provide a novel therapeutic approach for treating metabolic syndrome. This concept has spurred large scale medicinal chemistry efforts in the pharmaceutical industry for the design of 11β-HSD1 inhibitors. High resolution X-ray crystal structures of inhibitors in complex with the enzyme have facilitated the structure-based design of diverse classes of molecules. A summary of binding modes, trends in structure- activity relationships, and the pharmacodynamic data of inhibitors from each class is presented.
Keywords: Metabolic syndrome, 11β-HSD1, inhibitors, structure-based drug design, x-ray crystal structures, binding modes, structure-activity relationship, natural products, cortisone, cortisol, triazoles, aminothiazolones, sulfonamides, pharmacodynamic, hypothalamic-pituitary-adrenal axis, 11-hydroxyste-roid dehydrogenase types 1 and 2, 11-keto group, glucocorticoid cortisone 1, Q177Y, I180V, I227V, E226A, whole body inhibition, tissue specific in-hibition, short-chain alcohol dehydrogenase/reductase, triterpene 18-glycyrrhetinic acid, Carbenoxolone, Triazole, cyclopropyl-4-fluorobenzyl group, 18-glycyrrhetinic acid, polar 4-(2-pyridyl)piperazin-1-yl, amide carbonyl oxygen, Ser170, Tyr183 phenol, 3-fluoro-4-methyl substitution, cyclo-octylamino compound, benzylamino compounds, Leu171, aminothiazolone ring, thiazolone ring, AMG-221, sulfonamide, (2-hydroxy-1,1,1-trifluoro)-2-propyl group, CYP3A4 inhibitor
Current Pharmaceutical Biotechnology
Title: Structure Based Design of 11β-HSD1 Inhibitors
Volume: 11 Issue: 7
Author(s): Suresh B. Singh and Colin M. Tice
Affiliation:
Keywords: Metabolic syndrome, 11β-HSD1, inhibitors, structure-based drug design, x-ray crystal structures, binding modes, structure-activity relationship, natural products, cortisone, cortisol, triazoles, aminothiazolones, sulfonamides, pharmacodynamic, hypothalamic-pituitary-adrenal axis, 11-hydroxyste-roid dehydrogenase types 1 and 2, 11-keto group, glucocorticoid cortisone 1, Q177Y, I180V, I227V, E226A, whole body inhibition, tissue specific in-hibition, short-chain alcohol dehydrogenase/reductase, triterpene 18-glycyrrhetinic acid, Carbenoxolone, Triazole, cyclopropyl-4-fluorobenzyl group, 18-glycyrrhetinic acid, polar 4-(2-pyridyl)piperazin-1-yl, amide carbonyl oxygen, Ser170, Tyr183 phenol, 3-fluoro-4-methyl substitution, cyclo-octylamino compound, benzylamino compounds, Leu171, aminothiazolone ring, thiazolone ring, AMG-221, sulfonamide, (2-hydroxy-1,1,1-trifluoro)-2-propyl group, CYP3A4 inhibitor
Abstract: Controlling elevated tissue-specific levels of cortisol may provide a novel therapeutic approach for treating metabolic syndrome. This concept has spurred large scale medicinal chemistry efforts in the pharmaceutical industry for the design of 11β-HSD1 inhibitors. High resolution X-ray crystal structures of inhibitors in complex with the enzyme have facilitated the structure-based design of diverse classes of molecules. A summary of binding modes, trends in structure- activity relationships, and the pharmacodynamic data of inhibitors from each class is presented.
Export Options
About this article
Cite this article as:
B. Singh Suresh and M. Tice Colin, Structure Based Design of 11β-HSD1 Inhibitors, Current Pharmaceutical Biotechnology 2010; 11 (7) . https://dx.doi.org/10.2174/138920110792927748
DOI https://dx.doi.org/10.2174/138920110792927748 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of DNA Methyltransferase Inhibitors for the Treatment of Neoplastic Diseases
Current Medicinal Chemistry Allosteric Inhibitors of SHP2: An Updated Patent Review (2015-2020)
Current Medicinal Chemistry Therapeutic Options for the Management of Aromatase Inhibitor- Associated Bone Loss
Endocrine, Metabolic & Immune Disorders - Drug Targets Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Recent Patents on Anti-Cancer Drug Discovery Inflammation and Antiangiogenesis in Cancer
Current Medicinal Chemistry FXR, A Therapeutic Target for Bile Acid and Lipid Disorders
Mini-Reviews in Medicinal Chemistry Comparative Pharmacokinetics and Metabolism Studies in Lean and Diet- Induced Obese Mice: An Animal Efficacy Model for 11β -Hydroxysteroid Dehydrogenase Type 1 (11β -HSD1) Inhibitors
Drug Metabolism Letters Multitarget Network Strategies to Influence Memory and Forgetting: The Ras/Mapk Pathway as a Novel Option
Mini-Reviews in Medicinal Chemistry The Role of Amino Acids in the Modulation of Cardiac Metabolism During Ischemia and Heart Failure
Current Pharmaceutical Design Endometriosis Management: Workflow on Genomics and Proteomics and Future Biomolecular Pharmacotherapy
Current Medicinal Chemistry Networking Between γc and GH-R Signaling in the Control of Cell Growth
Current Signal Transduction Therapy Antileukotriene Drugs: Clinical Application, Effectiveness and Safety
Current Medicinal Chemistry Recent Patents Related to Phosphorylation Signaling Pathway on Cancer
Recent Patents on DNA & Gene Sequences PPAR Ligands for Metabolic Disorders
Current Topics in Medicinal Chemistry Immunomodulatory Drugs: IMiDs in Acute Myeloid Leukemia (AML)
Current Drug Targets Leukotrienes, Antileukotrienes and Asthma
Mini-Reviews in Medicinal Chemistry In Vitro and In Vivo Approaches for Screening the Potential of Anticancer Agents: A Review
Current Drug Discovery Technologies Mechanisms of Neuronal Injury and Death in HIV-1 Associated Dementia
Current HIV Research Molecular Dynamics Simulations, Challenges and Opportunities: A Biologist’s Prospective
Current Protein & Peptide Science HIV-1, Methamphetamine and Astrocyte Glutamate Regulation: Combined Excitotoxic Implications for Neuro-AIDS
Current HIV Research